Vireo Growth Inc.
Vireo Growth Inc. is a U.S.-based cannabis company that cultivates, manufactures, distributes, and sells cannabis products through wholesale channels and owned or operated dispensaries. Its operations are concentrated in state-licensed markets across Maryland, Minnesota, Missouri, Nevada, New York, and Utah.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueGrowing cannabis plants and producing raw material for downstream processing and sale.
Processing cultivated cannabis into finished products for wholesale and retail channels.
Selling cannabis products to third-party dispensaries and other licensed buyers.
Operating Green Goods and other dispensaries that sell directly to approved patients and adult-use customers.
Products
Reported · share of revenue- Retail81.8 %
- Wholesale Product18.2 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Vireo sells to two main customer groups: licensed third-party dispensaries in wholesale markets and end consumers who purchase through its owned or operated retail stores. Its retail customers include approved medical patients and adult-use consumers in the states where it operates, while wholesale customers buy finished cannabis products for resale.
Buy cannabis products through dispensaries for approved medical use and consistent product access.
Purchase cannabis products at retail stores in states where adult-use sales are permitted.
Buy cannabis products for resale in licensed third-party retail outlets.
Strategy
Vireo’s stated focus is on building a customer-centric cannabis platform across cultivation, manufacturing, wholesale, and retail. The company emphasizes operating in limited-license markets, using its dispensary network and state-licensed subsidiaries to control access to customers and product flow.
Owning cultivation, manufacturing, wholesale, and retail improves control over supply and customer access.
Restricted licensing can support durable local market positions and distribution access.
Direct retail relationships can improve brand visibility and capture more end-market demand.
Geography
Vireo operates in six U.S. states: Maryland, Minnesota, Missouri, Nevada, New York, and Utah. Its retail footprint spans 36 dispensaries across these markets, while wholesale sales are concentrated in Maryland, Minnesota, and New York. The state-by-state structure matters because cannabis licensing, retail access, and market maturity vary materially by jurisdiction.
Risks
Vireo faces regulatory and licensing risk because cannabis operations depend on state approvals, local compliance, and market-specific rules. It also faces execution risk from operating across multiple states and business lines, plus industry-wide risks such as price pressure, product quality control, and changes in cannabis laws.
- Regulatory approval risk for transactions and asset salesImpact: HighLikelihood: Medium
Cannabis assets often require government and regulatory consent before closing.
Exposure: Asset Sale / RSA-related transactions
- Transaction completion riskImpact: HighLikelihood: Medium
The company may not obtain approvals or satisfy conditions precedent, preventing expected benefits.
Exposure: Acquisition / restructuring-related activity
- Multi-state operating complexityImpact: MediumLikelihood: Medium
Different state rules, retail footprints, and wholesale channels increase operational complexity.
Exposure - Cannabis market competition and pricing pressureImpact: MediumLikelihood: Low
Wholesale and retail cannabis markets can be fragmented and price competitive.
Exposure: Wholesale and dispensary sales
Accounting
Judgemental itemsWholesale and retail cannabis sales may be recognized at different points in the transaction cycle.
Impact: Affects quarterly comparability and reported revenue timing
Cannabis inventory is subject to quality, yield, and obsolescence estimates.
Impact: Can change cost of sales and margin presentation
The company has a large equity award base that creates recurring non-cash expense.
Impact: Affects operating expenses and adjusted earnings reconciliation
Financing actions can create large one-time charges and ongoing interest costs.
Impact: Can materially affect other expense and net income
Changes in the value of held warrants can create non-operating gains or losses.
Impact: Introduces earnings volatility unrelated to core cannabis operations
Similar listed companies
Publicly listed companies with a comparable business focus.
Verano Holdings Corp.
VRNO · Agricultural Production-Crops
Ayr Wellness Inc.
AYRWF · Medicinal Chemicals & Botanical Products
Marimed Inc.
MRMD · Medicinal Chemicals & Botanical Products
Trulieve Cannabis Corp.
TRLV · Medicinal Chemicals & Botanical Products
Jushi Holdings Inc.
JUSH · Medicinal Chemicals & Botanical Products
Green Thumb Industries Inc.
GTBIF · Agricultural Production-Crops
Last updated: 24/09/2026